U.S. government health regulators will allow GlaxoSmithKline to continue selling a controversial diabetes pill but will restrict access to the once-blockbuster drug because of heart attack risks. GlaxoSmithKline - Health - Avandia - Conditions and Diseases - Food and Drug Administration
Diabetes Pill Avandia To Be Severely Restricted
msnbc.com: Top msnbc.com headlines, NBC News
Thu, 09/23/2010 - 8:58am
Sections: living
RELATED ARTICLES
- Study: Annual cost of diabetes reaches $245B
The growing toll of diabetes cost the nation a record high $245 billion in 2012, a 41% increase from $174 billion in 2007, according to new research released today. The study Economic Costs of Diabetes in the U.S. in 2012, commissioned by the American Diabetes Association, estimated the health care and work-related costs of diagnosed diabetes. More - Heart Attack Grill's 'spokesman' dies of heart attack
The unofficial spokesman for the infamous Las Vegas restaurant Heart Attack Grill has, you guessed it, died of a heart attack. More - Flu relief especially tricky for moms-to-be
Pregnant women should get flu shots, health experts say, but they've got to be more careful than others about over-the-counter medications for relief. More - Sotomayor tells life story shaped by disease, overcoming adversity
Very soon after being diagnosed with diabetes, 7-year-old Sonia Sotomayor decided she would not depend on the adults in her life — a distant, overworked mother, a doomed, alcoholic father — for the daily shots of insulin that would keep her alive. More - McAfee says he faked heart attack
American technology pioneer John McAfee said he faked a heart attack while detained in Guatemala to buy time for his attorney to file a series of appeals that ultimately prevented his deportation to Belize, hastening the government's decision to send him back to the United States. More
BING NEWS:
- Wegovy Maker Novo Nordisk Says New Pill Shows 14% Reduction in Heart Attacks, Strokes in Diabetic Patients
Rybelsus is an oral form of semaglutide, the active ingredient in the company’s blockbuster Ozempic and Wegovy diabetes and weight-loss drugs, and was tested in the trial on diabetic patients ...
10/21/2024 - 12:24 am | View Link - Wegovy Maker Novo Nordisk's Oral Diabetes Pill Cuts Heart Attacks, Stroke Events By 14%
The SOUL trial was initiated in 2019 and enrolled 9,650 people with type 2 diabetes and established cardiovascular disease (CVD) and/or chronic kidney disease (CKD). Also Read: Novo Nordisk’s ...
10/20/2024 - 9:46 pm | View Link - More
Welcome to Wopular
Wopular is an
online newspaper rack,
giving you a summary view of the top headlines from the top news sites.
Senh Duong (Founder)
Wopular,
MWB,
RottenTomatoes
MoviesWithButter : Our Sister Site
- "Expendables 4" Starts Shooting This Fall, Says Randy Couture at the Arnold Sports Festival more
- “Expendables 4” Gets Funding Interest from “Ip Man 3” Financier more
- "Ip Man 3" Distributor Suspected of Box Office Fraud, Parent Company Loses $200M in Market Cap more
- Yen Targets "Ip Man 4" for 2018 Release; Discusses Film with Director, Producer more
- "Ip Man 3" Shatters Expectations with $72M Opening [China Box Office] more